Let's compare costs. These are the prices of Big P
Post# of 36728
Posted On: 10/22/2013 11:28:48 AM
Let's compare costs. These are the prices of Big Pharma cancer pharmaceuticals that may extend the life of an advanced cancer patient from a few weeks to a few months. Average survival time is 42 days when a combination of these agents are used. Treating lung-cancer patients with so-called "breakthrough" Erbitux, a pharmaceutical that costs up to $80,000 for an 18-week regimen, was found to prolong survival by only 1.2 months on average, according to NCI. These pills do not cure the cancer, they just marginally prolong the dying time.
NCI estimated that extending the lives of the 550,000 Americans who die of cancer annually by one year would cost $440 billion,
Cost of cancer pills only. All the other elements of cancer treatment are not included. Zaltrap, $11,000/month; Yervoy, $39,000/month; Provenge, $93,000/course of treatment; Erbitux, $8,400/month; Avastin $5000/month; Gleevec, $92,000/year; Tasigna, $115,000/year; Sprycel, $123,000/year.
Dharmanol costs $25 for six tablets.
NCI estimated that extending the lives of the 550,000 Americans who die of cancer annually by one year would cost $440 billion,
Cost of cancer pills only. All the other elements of cancer treatment are not included. Zaltrap, $11,000/month; Yervoy, $39,000/month; Provenge, $93,000/course of treatment; Erbitux, $8,400/month; Avastin $5000/month; Gleevec, $92,000/year; Tasigna, $115,000/year; Sprycel, $123,000/year.
Dharmanol costs $25 for six tablets.
(0)
(0)SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼